When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is ...

Confluent, Inc. (Nasdaq:CFLT), the data streaming pioneer, today announced Confluent Intelligence, the fastest path to building and powering context-rich, real-time artificial intelligence (AI). Built ...

Confluent is a compelling "Buy" as Q3 results reinforce its robust ~20% subscription revenue growth and significant total addressable market. CFLT trades at attractive valuation multiples (6.3x ...

A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...

Thinking about what to do next with Confluent stock? You are not alone. After a few years of wild swings, investors are debating whether now is the right moment to buy, sell, or simply hang tight. The ...

CEO Edward Kreps highlighted strong Q3 results, stating, “We delivered a strong Q3, exceeding the high end of all guided metrics. Q3 subscription revenue grew 19% to $286 million. Confluent Cloud ...

Kyowa Kirin Co ((KYKOF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...

The shingles vaccine is intended to prevent shingles, a painful rash caused by the reactivation of the varicella-zoster virus, also known as herpes zoster — but a new study suggests that it could have ...

Confluent (CFLT) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.1 per share a year ago. These figures are ...

The latest trends in software development from the Computer Weekly Application Developer Network. Officially just known as ‘Current’ – and we say this every year, Confluent doesn’t necessarily include ...